MedPath

Diagnostic and Prognostic Significance of Computerized Cytologic Morphometry of the Thyroid Neoplasm

Recruiting
Conditions
Computerized Cytomorphometry
Interventions
Other: computerized cytomorphometry
Registration Number
NCT03105648
Lead Sponsor
National Taiwan University Hospital
Brief Summary

The prevalence of thyroid nodule is worldwide high. About 40% of normal population has thyroid nodules and about 5% are malignancy. It is important to differentiate malignancy from benign nodules because the management is completely different. Nowadays, the gold standard is fine needle aspiration cytology (FNAC) examination. The overall sensitivity and specificity is fair (\~90%), but still has its limitation that some results are indeterminate in about 15% of the nodules. These obstacles are especially troublesome for papillary and follicular thyroid cancer that leads to delayed diagnosis, incomplete resection, and repeated operation. Preoperative evaluation of the prognosis is extraordinary important for cancer management. However, current prognostic scoring systems is only applicable after surgery. Hence, we urgently need a better risk-stratification system for individual-tailored treatment, and genetic-based computerized morphometry study seems to be the most realistic and promising one. The goal of this study is to propose a reliable method for diagnosis and prognosis of papillary thyroid cancer and follicular thyroid cancer through analyzing cellular morphologic characteristics.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • patients who previously had received thyroid fine needle aspiration cytology examination
Exclusion Criteria
  • patients who are younger than 20 years old

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
thyroid cancercomputerized cytomorphometry-
benign thyroid nodulescomputerized cytomorphometry-
Primary Outcome Measures
NameTimeMethod
cytomorphometry of the cells2016/4/20-2026/4/20

cytologic characteristics of the cells

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath